Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- KLAR.ST
- Price
- 1.17
- Stock movement down
- -0.05 (-4.12%)
- Company name
- Klaria Pharma Holding AB
- Exchange
- (ST ,
- Currency
- SEK )
- Sector
- Healthcare >Drug Manufacturers - Specialty & Generic
- Market cap
- 151.17M
- Ent value
- 202.07M
- Price/Sales
- -
- Price/Book
- 11.70
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -16.73%
- 1 year return
- 377.46%
- 3 year return
- -39.57%
- 5 year return
- -21.47%
- 10 year return
- -
Last updated: 2025-04-12
DIVIDENDS
KLAR.ST does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | - |
| Price to Book | 11.70 |
| EV to Sales | -28.31 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 129.76M |
| EPS (TTM) | -0.32 |
| FCF per share (TTM) | -0.12 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | -7.14M |
| Gross profit (TTM) | -7.14M |
| Operating income (TTM) | -14.53M |
| Net income (TTM) | -41.64M |
| EPS (TTM) | -0.32 |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | 100.10% |
| Operating margin (TTM) | 203.53% |
| Profit margin (TTM) | 583.44% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 537.00K |
| Net receivables | 0.00 |
| Total current assets | 64.34M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 0.00 |
| Total assets | 64.36M |
| Accounts payable | 0.00 |
| Short/Current long term debt | 0.00 |
| Total current liabilities | 3.10M |
| Total liabilities | 51.44M |
| Shareholder's equity | 12.92M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -15.18M |
| Capital expenditures (TTM) | 0.00 |
| Free cash flow (TTM) | -15.18M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -322.37% |
| Return on Assets | -64.70% |
| Return on Invested Capital | -322.37% |
| Cash Return on Invested Capital | -117.48% |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 1.23 |
| Daily high | 1.24 |
| Daily low | 1.14 |
| Daily Volume | 218K |
| All-time high | 17.00 |
| 1y analyst estimate | 1.00 |
| Beta | 0.44 |
| EPS (TTM) | -0.32 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| KLAR.ST | S&P500 | |
| Current price drop from All-time high | -93.15% | -12.89% |
| Highest price drop | -99.03% | -56.47% |
| Date of highest drop | 12 Apr 2024 | 9 Mar 2009 |
| Avg drop from high | -56.10% | -11.07% |
| Avg time to new high | 96 days | 12 days |
| Max time to new high | 1569 days | 1805 days |
COMPANY DETAILS
Marketcap
151.17M
Marketcap category
Small-cap
Description
Klaria Pharma Holding AB (publ.) operates as a pharmaceutical company. It develops Sumatriptan for the treatment of migraine. The company also develops Epinephrine/Adrenaline, which is in Phase I clinical trial for the treatment of acute allergic reaction. In addition, its pre-clinical product is Sirolimus for prevention of organ transplant rejection. Further, the company focuses on the commercialization of cannabis/cannabinoids. Klaria Pharma Holding AB (publ.) was incorporated in 2014 and is headquatered in Uppsala, Sweden.
Employees
5
Website
Investor relations
-
SEC filings
CEO
Country
Sweden
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
No events found
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found